Conor Joseph Mulrooney

Phagenesis Ltd. develops a treatment for dysphagia. Its product Phagenyx consists of a base station and a treatment catheter which in combination enable the healthcare professional to deliver personalized dysphagia treatment for every patient. The company was founded by Conor Joseph Mulrooney and Shaheen Hamdy in 2007 and is headquartered in Manchester, the United Kingdom.

Myconostica Ltd. developed molecular diagnostic fungal testing kits. The company was founded in February 2006 and is headquartered in Cambridge, the United Kingdom.

The University of Manchester Intellectual Property Ltd. (UMIP) manages intellectual property for the University of Manchester. Formed in 2004, UMIP is a limited company wholly-owned by the University and located in Manchester, UK. They operate independently of the University. The University traces their history back to 1851 and more recently to 2004 when the University formally combined with UMIST (University of Manchester Institute of Science and Technology) to create a single university. UMIP acts as a technology transfer company in the UK. They have access to proof of concept funds to develop very early stage inventions to a phase where they become propositions capable of attracting investments. They also have investment funds to develop young start-up companies, along with the skills and network necessary to draw in the larger sums of external venture capital. UMIP works with researchers, entrepreneurs, business people, professional advisers and investors to achieve their goals.

Hologic Ltd. manufactures life sciences products and services with two divisions, Molecular Diagnostics and Research Products & Services. The firm has laboratories, manufacturing and operations in the USA, UK and France. It provides test kits, reagents and services to two synergistic markets. It focuses on these niche opportunities with products, patents, expertise and acquisitions. The company was founded in 1992 and is headquartered in Wythenshawe, the United Kingdom.